US

Nadji Sourena

This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadji Sourena. Retrieved from https://idiyas.com/inventor/nadji-sourena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Contributions of Nadji Sourena in Biopharmaceutical Innovations

Nadji Sourena is a prominent figure in the biopharmaceutical sector in the United States. Currently associated with Reliable Biopharmaceutical Corporation, he plays a significant role in the field of drug development and biotechnology.

Latest Patents

As of now, Nadji Sourena holds no patents. However, his contributions to the biopharmaceutical industry continue to influence advancements and innovations within the sector.

Career Highlights

Nadji Sourena has had a remarkable career at Reliable Biopharmaceutical Corporation, focusing on research and development. His expertise is instrumental in driving projects aimed at improving healthcare solutions. Despite not holding any patents yet, his work and leadership contribute greatly to the company's mission of developing innovative therapies.

Collaborations

Throughout his career, Nadji Sourena has engaged in numerous collaborations within the biopharmaceutical community. By partnering with research institutions and universities, he has cultivated relationships that foster knowledge sharing and innovation, significantly strengthening the field.

Conclusion

In conclusion, Nadji Sourena stands as a dedicated professional in the biopharmaceutical industry. Although he currently holds no patents, his ongoing efforts and collaborations at Reliable Biopharmaceutical Corporation reflect his commitment to advancing healthcare technologies and the pursuit of innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…